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ABSTRACT 
Background: Although psychological interventions are recommended for the management of 
coronary heart disease (CHD), there remains considerable uncertainty regarding their 
effectiveness.  
Design: Systematic review and meta-analysis of randomised controlled trials (RCTs) of 
psychological interventions for CHD. 
Methods: The Cochrane Central Register of Controlled Trials, MEDLINE, EMBASE, CINAHL, 
and PsycINFO were searched to April 2016. Retrieved papers, systematic reviews, and trial 
registries were hand-searched. We included RCTs with at least six months of follow-up, 
comparing the direct effects of psychological interventions to usual care for patients following 
myocardial infarction or revascularisation, or with a diagnosis of angina pectoris or CHD defined 
by angiography. Two authors screened titles for inclusion, extracted data, and assessed risk of 
bias. Studies were pooled using random effects meta-analysis and meta-regression was used to 
explore study-level predictors. 
Results: 35 studies with 10,703 participants (median follow-up 12 months) were included. 
Psychological interventions led to a reduction in cardiovascular mortality (relative risk 0.79, 95% 
confidence interval (CI) 0.63 to 0.98), although no effects were observed for total mortality, 
myocardial infarction, or revascularisation. Psychological interventions improved depressive 
symptoms (standardised mean difference (SMD) -0.27, 95% CI -0.39 to -0.15), anxiety (SMD -
0.24, 95% CI -0.38 to -0.09), and stress (SMD -0.56, 95% CI -0.88 to -0.24) compared with 
controls. 
Conclusions: We found that psychological intervention improved psychological symptoms, and 
reduced cardiac mortality for people with CHD. However, there remains considerable 
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uncertainty regarding the magnitude of these effects, and the specific techniques most likely to 
benefit people from different presentations of CHD. 
 
Abstract word count: 249 words 
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INTRODUCTION 
Coronary heart disease (CHD) is the single leading cause of death globally, accounting for 
around a third of all deaths.1 This mortality rate is falling, and many more people are living with 
CHD and require support to manage their symptoms and prognosis. Cardiac events or cardiac 
surgery can be significant and distressing life events; mental health comorbidity is common, 
greatly exceeding the rates observed within the general population.2, 3 Anxiety and depression are 
also independent risk factors for cardiovascular morbidity and mortality.4, 5 Thus the need to 
address stress, psychosocial factors (e.g. lack of social support), and other underlying mood 
disorders, is recognised within conventional cardiac care in Australia,6 Europe7, 8 and the US.4  
 
A range of psychological therapies have been employed as part of secondary prevention to 
improve psychological outcomes (as opposed to facilitating cardiovascular risk factor reduction). 
Examples include relaxation and stress management, treatments for mood disorders, or 
enhancing disease adjustment and coping strategies. Therapies have been used both in unselected 
cardiac populations, or targeted at cardiac patients with established psychopathologies. In 2011, 
a Cochrane review9 synthesised 24 trials testing the direct effects of psychological interventions 
on cardiac and psychological outcomes compared with usual care. This review observed marked 
variation in the psychological interventions tested across studies. Meta-analysis found no 
conclusive evidence that psychological interventions had an effect on total mortality and 
cardiovascular morbidity, although a potential effect on cardiac mortality was observed (5 trials, 
3893 participants; relative risk (RR) 0.80, 95% confidence interval (CI) 0.64 to 1.00). There was 
some evidence that psychological interventions improved depressive symptoms (12 trials, 5041 
participants; standardised mean difference (SMD) -0.21, 95% CI -0.48 to -0.08) and anxiety (8 
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trials, 2771 participants; SMD -0.25, 95% CI -0.35 to -0.03), although the 95% confidence 
intervals were wide and estimates lacked precision. This paper is an update of this Cochrane 
review, which is needed now due to the publication of a number of relevant new trials, combined 
with the considerable uncertainties in the evidence regarding the impact of psychological 
interventions on clinical events, psychological outcomes and health-related quality of life. 
 
METHODS 
We conducted this third update of this Cochrane review10 in accordance the Cochrane 
Handbook11, and reported it following the PRISMA guidance12 (Supplementary figure 1 for 
PRISMA flow chart). Although the protocol was first published on the Cochrane Database of 
Systematic Reviews in 2000, this review builds on the substantively revised protocol 
implemented in the second update.9 
Data searches and sources 
Search terms from the 2011 review9 were updated and CENTRAL (Cochrane Central Register of 
Controlled Trials), MEDLINE (Ovid), EMBASE (Ovid), PsychINFO (Ovid) and CINAHL 
(EBSCO) were searched to April 2016. We searched the WHO International Clinical Trials 
Registry Platform and the US Clinical Trials.gov registry for active clinical trials (accessed June 
2016). No language limitations were imposed on the searches (Supplementary methods 1).  
Study selection 
We selected randomised controlled trials (RCTs) comparing the direct effects of a psychological 
intervention compared with a usual care control group for adults with CHD, with or without 
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clinical psychopathology. Participants included those who had experienced a myocardial 
infarction (MI), a revascularisation procedure (coronary artery bypass grafting [CABG] or 
percutaneous coronary intervention [PCI]), angina pectoris, or angiographically-defined CHD. 
Participants could receive cardiac rehabilitation as long as this was part of usual medical care 
and offered routinely to both trial arms. Studies where psycho-pharmacology was offered solely 
or disproportionately to the treatment group in conjunction with the offer of psychological 
interventions were included. Studies testing psychological interventions in comorbid populations 
(e.g. patients with depression and either CHD or diabetes) were deemed eligible for inclusion as 
long as outcome data could be extracted for individuals with CHD. We excluded studies where 
over 50% of the sample had other cardiac conditions (e.g. heart failure), or had undergone 
cardiac resynchronisation therapy or received implantable defibrillators.  
Eligible interventions included those addressing stress or low mood, or enhancing coping 
strategies, either alone or in combination. Studies evaluating interventions based on 
psychological principles (e.g. motivational interviewing), which were solely directed at 
improving adherence to other efficacious treatments (e.g. medication adherence or exercise) or 
the modification of cardiac risk factors (e.g. smoking, diet), were excluded. We only selected 
studies where the psychological interventions were delivered by health care workers who had 
been trained in their delivery. 
Finally, we selected trials reporting outcomes for a minimum of six months post-randomisation, 
and reporting at least one of the primary outcomes (reported below). 
Two reviewers (LA, and SR or CJ) independently assessed all identified titles/abstracts for 
possible inclusion, with full reports obtained and assessed for any potentially relevant references. 
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Any disagreements between the reviewers were resolved by discussion. Where necessary, studies 
were translated into English. 
Data extraction and management 
Event rate data were extracted for the dichotomous primary outcomes of total mortality, cardiac 
mortality, cardiovascular morbidity (non-fatal MI, and revascularisation procedures [CABG, 
PCI]). Means and standard deviations were extracted for the continuous primary outcomes of 
validated measures assessing symptoms of depression, anxiety or stress. In addition, data were 
extracted for secondary outcomes regarding other validated measures of psychological function, 
health-related quality of life (HRQL) and cost-effectiveness. 
One reviewer (LA) extracted study and participant characteristics, intervention and comparator 
descriptors, and outcomes from included studies using a standardised data extraction form. A 
second author (SR or CJ) checked the extracted data for accuracy, and disagreements were 
resolved by discussion. Outcome data were independently extracted by two reviewers (LA and 
SR). Related publications of the same study were assessed for additional data. Authors were 
contacted, where necessary, to provide additional information. 
Assessment of risk of bias and overall quality of evidence 
The Cochrane Collaboration's core risk of bias items and three further items deemed relevant to 
this review were assessed, with each study assigned a ‘low’, ‘high’ or ‘unclear’ risk of bias for 
each item. A detailed description for the three additional criteria (groups balanced at baseline; 
use of intention-to-treat analysis; groups receiving comparable treatment except the 
psychological treatment) can be found elsewhere.10 One reviewer extracted these data, and a 
second reviewer checked the extracted data for accuracy. For each outcome, the overall quality 
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of evidence was assessed by employing the Grading of Recommendations Assessment, 
Development and Evaluation (GRADE) approach to interpret result findings, using GRADEpro 
GDT software.13 
Data synthesis and analysis 
Dichotomous outcomes, relating to mortality and cardiovascular morbidity, were expressed as 
risk ratios with 95% CIs. Continuous outcomes, relating to psychological outcomes, were 
expressed as standardised mean differences (SMD) with 95% CIs. For primary outcomes, data 
were pooled using a conservative random effects model due to the substantial clinical 
heterogeneity in psychological treatments and study populations identified. Heterogeneity was 
explored qualitatively and quantitatively (using the I2 statistic and chi-square test of 
heterogeneity). Small study bias was examined through visual inspection of the funnel plot and 
the use of Egger tests.14  
For secondary outcomes where there were insufficient data, or where it was inappropriate to 
combine studies statistically, a narrative review was presented. 
Exploratory meta-regression was undertaken to examine potential treatment effect modifiers 
(Table 1) on the selected outcomes of total mortality, cardiac mortality, depression and anxiety. 
The explanatory variables were selected a priori following the approach outlined in the 2011 
update,9 although we restricted analyses to a smaller group of variables due to concerns over data 
quality. Given the relatively small ratio of trials to covariates, meta-regression was limited to 
univariate analysis.15  
All statistical analyses were performed using Review Manager 5.3 Software16 and STATA 
version 13.0 (StataCorp, College Station, Texas).17 
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RESULTS 
Selection and inclusion of studies 
The 2011 review identified 24 studies that met the inclusion criteria. On review, three studies 
were excluded due to either an ineligible patient population,18 an inappropriate control group,19 
or a non-randomised trial design20 and therefore 21 of the 24 studies were included in this 
update. Searches between 2009 and 2016 yielded 6359 titles and abstracts (Supplementary figure 
1). A total of 123 papers were reviewed and 14 studies (2577 participants) met the inclusion 
criteria.21-34 Thus a total of 35 studies (81 publications) were included, reporting data from 
10,703 participants (Supplementary table 1 provides a full bibliography).  
Study, participant and intervention characteristics 
Studies 
Most studies were published in Europe (19 studies) or North America (12 studies) (Table 2). 
While studies randomised between 42 and 2481 participants, most were small, with a median 
sample size of 123 participants (IQR 73 to 204). The median length of follow-up was 12 months 
(IQR range 12 to 29 months); longer follow-ups (over 30 months) were restricted to clinical 
events data extracted from routine records rather than psychological outcomes.  
Participants 
The median of study mean ages was 59.6 years, and the median proportion of males was 77% 
(Table 2). The most common cardiac indication upon study referral was an MI (65.7%), with 
around a third having undergone some form of revascularisation procedure (27.4%). Twelve 
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studies required participants to have a clinical psychopathology (most commonly depression) at 
baseline to satisfy an eligibility criterion. In unselected cardiac populations nine studies reported 
rates of depression of between 3.8%35 and 53%36 and three studies reported anxiety of 32%33, 37 
and 53%38 (some papers reported both anxiety and depression). Only three excluded individuals 
with psychopathology at baseline and eleven studies either did not measure psychological 
outcomes at baseline, or did not report them. 
Interventions 
The number of contact hours in psychological interventions varied considerably, ranging from an 
average of 2 hours to 96 hours (31 studies; Table 2). Over half were delivered in groups (20 
studies), or a mix of group and individual sessions (five studies). 11 studies reported family 
involvement in treatment.  
Although the quality of reporting of interventions was highly variable, based on available 
descriptions 23 studies evaluated psychological treatments with multiple treatment aims and 
components. Common treatment aims included managing stress (22 studies), depression (17 
studies), anxiety (16 studies) and Type A behaviour including anger and hostility (12 studies), 
and achieving improved disease adjustment (11 studies). Common treatment components 
included relaxation techniques (20 studies), self-awareness and self-monitoring (20 studies), 
emotional support or client led discussion (15 studies), and cognitive challenge or cognitive 
restructuring techniques (19 studies). Many interventions included co-interventions aimed at 
raising awareness of cardiac risk factors (16 studies), and the targeting of behaviours relating to 
cardiac risk reduction (e.g. smoking, salt intake; 19 studies). Only three studies incorporated the 
co-prescribing of pharmacological drugs where it was deemed clinically appropriate.21, 29, 39 
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Risk of bias and GRADE assessment 
The overall risk of bias scores varied between items assessed (Supplementary table 2). The 
quality of reporting was highly variable, with an unclear risk of bias for over half the studies for 
domains relating to randomisation procedures and the blinding of outcome assessment. This 
limited our ability to judge risk of bias, and thus downgrading the GRADE quality of evidence 
across all outcomes (Tables 3 and 4).  
Some outcomes were also downgraded due to a lack of precision around the estimated effect 
(non-fatal MI, stress), significant heterogeneity observed (anxiety, stress) and/or the risk of 
publication bias (cardiac mortality, anxiety). Thus the GRADE ratings were moderate (total 
mortality, revascularisation), low (cardiac mortality, non-fatal MI, anxiety, depression) or very 
low (stress) for all outcomes. 
Outcome results 
For mortality and cardiovascular morbidity data, the attrition at follow-up was low with, for 
example, 1.7% of total mortality data missing from the pooled analysis of 23 studies. In contrast, 
the overall level of attrition of studies contributing to the pooled analyses was 17.7% for 
depression, 9.1% for anxiety, and 9.4% for stress. 
Mortality 
Pooled analysis of 23 studies (Table 3, Supplementary figure 2) found no evidence that 
psychological therapies reduced the risk of total mortality (7776 participants; RR 0.90, 95% CI 
0.77 to 1.05, I2=2%). However, there was evidence that psychological interventions reduced the 
risk of cardiac mortality (Table 3, Figure 1) when pooling data from 11 studies (4792 
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participants, RR 0.79, 95% CI 0.63 to 0.98, I2=0%), although there is some uncertainty in this 
finding as the quality of evidence is low. 
Cardiovascular morbidity 
There was no evidence of risk reduction for revascularisation procedures (Table 3, 
Supplementary figure 3) (13 studies, 6822 participants; RR 0.94, 95% CI 0.81 to 1.11, I2=8%) or 
for an occurrence of a subsequent non-fatal MI (Table 3, Supplementary figure 4) (13 studies, 
7845 participants; 0.82, 95% CI 0.64 to 1.05, I2=41%).  
Psychological outcomes 
Meta-analysis of 19 studies (5825 participants) found evidence that psychological interventions 
reduced depression symptoms compared with the comparator group (SMD -0.27, 95% CI -0.39 
to -0.15, I2=69%). Reductions in anxiety levels (12 trials, 3161 participants; SMD -0.24, 95% CI 
-0.38 to -0.09, I2=47%) and stress levels (8 trials, 1251 participants; SMD -0.56, 95% CI -0.88 to 
-0.24, I2=86%) in favour of the intervention group were also observed. However, there remains 
considerable uncertainty regarding treatment effects for all comparisons as the quality of 
evidence was either low or very low (Table 4). 
Statistical heterogeneity and small study bias 
Inspection of I² tests found significant levels of statistical heterogeneity in the meta-analyses of 
all psychological outcomes, but not mortality or morbidity data. Visual inspection of the funnel 
plots (data reported elsewhere10) shows some evidence of asymmetry for cardiac and depression, 
anxiety, stress, but not total mortality or other measures of cardiovascular morbidity. The Egger 
tests for funnel plot asymmetry were non-significant for the majority of primary outcomes, with 
the exceptions of cardiovascular mortality (P=0.04) and anxiety (P=0.012). This asymmetry 
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appeared to be due to an absence of small- to medium-sized studies with negative results 
regarding psychological interventions. 
Health-related quality of life 
HRQL was reported in ten studies (Supplementary table 3). Narrative review found statistically 
significant improvements in at least one dimension of HRQL in favour of psychological 
interventions in four studies,22, 28, 29, 40 while six studies26, 33, 35, 41-43 reported no between group 
differences. Of studies reporting significant treatment effects, two observed improvements 
restricted to mental health and/or life satisfaction components of HRQL,22, 40 a third study found 
improvements restricted to the physical health component,29 while the fourth study reported 
improvements in both physical and mental health components.28   
Cost effectiveness 
Only 2 studies reported any form of economic evaluation alongside trial data. Van-Dixhoorn 
199944 limited the economic evaluation to an examination of hospital costs arising from cardiac-
related hospital readmissions across a five-year follow-up. The authors reported the extra costs of 
individual relaxation training sessions (the intervention) were outweighed by the benefits (30% 
reduction in the number of days in hospital and 46% reduction in costs due to reduced 
readmissions for cardiac surgery). Davidson 201021 (see Ladapo 201245) examined HRQL, 
health care utilisation and costs of the intervention compared to usual physician care. The mean 
total health care costs (psychotropic medicines, ambulatory care, hospitalisations) was $1857 for 
the intervention group and $2797 for usual care (adjusted difference -$1229 per patient, 95% CI -
$2652 to $195, P=0.09), with a 98% probability that this approach would be considered cost 
effective if a willingness-to-pay threshold of $30,000 per quality-adjusted life-year gained was 
applied. 
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Meta-regression findings 
We found no significant predictors of intervention effects for total or cardiovascular mortality 
(Supplementary table 4) for any of the population or intervention characteristics explored in 
univariate meta-regression models. Meta-regression of psychological outcomes yielded only two 
statistically significant predictor variables. Psychological interventions combined with 
pharmacology for an underlying psychological disorder (P=0.003) were more effective at 
alleviating depression than interventions that were not (Supplementary table 4). Interventions 
recruiting participants with an underlying psychological disorder were more effective at 
alleviating anxiety than those delivered to unselected populations (P=0.03).  
 
DISCUSSION 
Main findings 
We updated a systematic review of the direct effects of psychological interventions for people 
with CHD. We found a reduction in cardiovascular mortality (7.3% to 5.5%, number needed to 
treat 56) with psychological interventions compared with usual care controls. No between group 
differences were observed for the rates of total mortality, non-fatal MI, or revascularisation 
procedures. Psychological interventions were found to achieve small to moderate improvements 
in depressive symptoms, anxiety and stress compared with controls, although there remains some 
uncertainty in these estimates.  
Narrative synthesis found some evidence of a positive effect on HRQL, although direct 
comparisons are problematic due to methodological differences between studies, such as the use 
of different HRQL measures. Only two studies conducted economic evaluations, with both 
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concluding that psychological therapies were likely to be cost effective, although this evidence 
requires replication in future research. 
We undertook an exploratory analysis seeking to identify potential effect modifiers from a range 
of population and intervention characteristics. In contrast to the previous update,9 we elected not 
analyse some the patient characteristics of study populations (e.g. sex or age) previously 
explored using meta-regression. Recent methodological guidance for systematic reviews of 
cardiac prevention studies,46 cautions against the analysis of patient characteristics in meta-
regression when aggregated at the study level. Statistically, study-level analysis is under-
powered compared with individual patient data meta-analysis. More importantly, however, this 
analysis is prone to ecological fallacy (or ‘aggregation bias’). 
Meta-regression failed to identify any predictor variables for the total and cardiovascular 
mortality, although this was not unexpected given the lack of statistical heterogeneity in the 
pooled analysis. Meta-regression for the outcomes of depression and anxiety, where considerably 
greater statistical heterogeneity was observed in pooled analysis, found only two predictor 
variables. For depression, the adjunct use of pharmacological therapy for the underlying 
psychological condition (where deemed clinically appropriate) may increase intervention 
effectiveness compared with interventions that did not. For anxiety, psychological interventions 
which recruited participants with CHD and an underlying psychological disorder appeared more 
effective than those delivered to unselected CHD populations. 
Findings in context 
Our study has further clarified findings from the 2011 update,9 with the precision of the effect 
estimates improving across all outcomes through the inclusion of new data from 14 studies (2577 
participants). We also present pooled data on stress levels for the first time. However, the meta-
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regression failed to replicate the effect modifiers (e.g. interventions targeting Type A behaviours, 
or involving family members) previously identified for the outcome of depression. This is likely 
to be attributable to the inclusion of a number of new studies, combined with the exclusion of 
data from two studies that had previously contributed data to these analyses.19, 47 
Although other systematic reviews have sought to explore effectiveness of psychological 
interventions for people with CHD,48, 49 direct comparisons are problematic due to important 
differences in study selection. For example, Welton et al.48 included studies testing both the 
direct and indirect effects of psychological interventions for people with CHD, whilst Dickens et 
al.49 included studies with a follow-up period of less than six months. In contrast to our findings, 
Welton et al.48 found no evidence that psychological interventions reduced cardiovascular 
mortality, although consistent with our findings no effect on total mortality was observed. There 
is also consistent evidence emerging across a body of empirical evidence that psychological 
interventions have small but consistent effects at alleviating symptoms of depression48, 49 and 
anxiety48 for people with CHD. Notwithstanding the uncertainty regarding the optimal methods 
of providing psychological care, this review lends further support to the international guidelines4, 
6-8 that addressing psychological health should be a core component of conventional cardiac 
prevention services.  
Study limitations 
The level of reporting of key risk of bias domains relating to randomisation procedures and the 
blinding of outcome assessment was poor, limiting our ability to judge risk of bias. Some 
outcomes were also downgraded due to a lack of precision around the estimated effect, 
significant heterogeneity observed and/or the risk of publication bias. Thus the GRADE quality 
of evidence ranged from moderate, low or very low across outcomes. 
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From the information reported, the majority of participants were men recruited post-MI, and our 
findings may be less generalizable to more diverse populations of women, or to individuals with 
other cardiac conditions using secondary prevention services.  
Another feature of the studies synthesised was the clinical heterogeneity, as studies often tested 
complex psychological interventions with multiple treatment targets and components; only a 
minority test the effectiveness of single component therapies (e.g. Van-Dixhoorn 199944 and 
Blumenthal 201634 tested a stress management intervention). The poor reporting of intervention 
components (e.g. the training received, or any ongoing supervision provided) and participant 
characteristics (for example, a third of studies did not report the presence of psychopathology at 
baseline) limited a detailed examination of the active ingredients of psychological techniques 
through meta-regression. While meta-analysis found evidence of small effects on a number of 
outcomes, there remains considerable uncertainty regarding which type of psychological 
techniques are most effective and for whom. The effectiveness of emerging, and potentially more 
beneficial psychological interventions has yet to be addressed: mindfulness, for example, may be 
more effective than traditional stress management approaches for individuals with high levels of 
health anxiety.50 In addition, given the likely low effect size (in terms of both psychological and 
cardiac benefit) of any psychological intervention targeted at a population with no obvious 
psychopathology, the latter is an important issue to address in future studies. A number of 
ongoing trials appear to be directly assessing some of these uncertainties.51-53 
Our review also excluded psychological interventions designed specifically to improve 
adherence to cardiac risk factor modification (e.g. medicines, lifestyle change); this was essential 
to reduce the clinical heterogeneity of interventions compared, but as a consequence our findings 
do not inform the wider evidence-base on the contribution of psychological techniques to 
optimise risk factor management.  
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While we were able to pool data for a number of important clinical and psychological outcomes, 
the breadth of outcome measures reported was often limited within studies. For example, while 
around two-thirds of studies (23/35) reported total mortality, less than a third of studies reported 
stress levels (8/35) or cardiovascular mortality (11/35) in a way that could be pooled. In addition, 
the reporting of psychological status of study populations at baseline was often omitted, and only 
a minority of studies reported other important outcomes, such as HRQL, or data that could be 
used to support health economic evaluation.  
Conclusions 
This updated Cochrane review found that psychological treatments had important health benefits 
among people with CHD, reducing the rate of cardiac mortality and alleviating the psychological 
symptoms of depression, anxiety, and stress. However, according to the GRADE methodology 
there remains uncertainty in these benefits and large-scale trials are still warranted. Future trials 
must provide a clearer reporting of their methods and interventions (perhaps following similar 
taxonomies of intervention components to those encouraged in health behaviour interventions54), 
assess a broader range of outcomes, and undertake health economic evaluation. There also 
remains uncertainty regarding who benefits most from treatment, and which types of 
psychological intervention yield the greatest benefit. Future trials that test the efficacy of specific 
psychological techniques are still needed, although this may prove challenging in real-world 
settings where patients may present with complex psychological needs that alter across the 
course of their recovery. Pragmatic trials of multifactorial interventions, delivered in a blended 
fashion, are also justified, but should be accompanied by pre-planned process evaluations (e.g. 
using sub-group analysis) to better understand the active ingredients of such complex 
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interventions.55 Future trials should also explore the optimal targeting of interventions for people 
with CHD with or without psychopathologies.  
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